Publications

Comparative Study
Journal Article
Ppublish 116 citations
Electronic publication date
March 28, 2001

View on Pubmed.gov 2982918 | View on doi.org 10.1172/JCI1117...

Human B lymphoma cell line producing B cell growth factor.

Search for publications in this journal J Clin Invest - 75(2):732-9

Abstract

Namalva, a human B cell lymphoma line, produced a factor with a molecular weight of approximately 60,000 which enhanced the proliferation of normal activated human B lymphocytes. The factor also enhanced the proliferation of certain B cell lines. It can be distinguished physiologically and biochemically from other lymphokines known to enhance B cell proliferation, namely, interleukin (IL) 1, IL 2, and interferon. The production of B cell growth factor by B cell tumor lines may contribute to their ability to grow autonomously and may reflect an important component of the neoplastic potential of the cell. B cell growth factor produced by tumors may also affect normal cells in vivo.

References

Nature. 1970 Aug 15;227(5259):680-5

Nature. 1984 Jul 12-18;310(5973):145-7

J Virol. 1976 Mar;17(3):935-49

J Immunol. 1977 Jan;118(1):77-82

Cited by 116 citations (total)

Journal Article Research Support, Non-U.S. Gov't

CD40 expression in Hodgkin's disease.

Electronic publication date January 1, 1994

Search for publications in this journal Am J Pathol

J T O'Grady [...] A S Krajewski et al.

CD40 is a transmembrane protein that belongs to a superfamily of proteins related to nerve growth factor receptor. CD40 is...

Journal Article

Association between B Cell Growth Factors and Primary Sjögren's Syndrome-Related Autoantibodies in Patients with Non-Hodgkin's Lymphoma.

Electronic publication date April 9, 2019

Search for publications in this journal J Immunol Res

Zhenhua Xian [...] Chun Gao et al.

Despite the overall success of using R-CHOP for the care for non-Hodgkin's lymphoma patients, it is clear that the disease...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances